Lung Disease News and Research

RSS

IP-10 and neopterin show promise as biomarkers for lung disease exacerbations

Australian researchers have identified interferon-γ inducible protein-10 and neopterin as promising sputum markers of acute exacerbations of obstructive lung disease.

29 Apr 2013

SLU study reveals that access to dermatologists limited for Medicaid-insured children with eczema

A recent Saint Louis University study revealed that Medicaid-insured children with eczema, an inflammatory skin condition that affects 20 percent children in the United States, do not have easy access to dermatologists.

29 Apr 2013

Longer looks: Paying the oncologist; plenty of diagnostic errors, a patient revolution

When the automatic spending cuts kicked in for Medicare this month, every doctor saw a 2 percent reduction in reimbursement from the government insurance program. But cancer doctors have made the most noise

26 Apr 2013

Study identifies seven new genetic regions associated with pulmonary fibrosis

A new genome-wide association study of more than 6,000 people has identified seven new genetic regions associated with pulmonary fibrosis. In findings published online in Nature Genetics on April 14, 2013, researchers at National Jewish Health, the University of Colorado and several other institutions found a number of genes associated with host defense, cell-cell adhesion and DNA repair, which provide clues to possible mechanisms underlying this currently untreatable disease.

20 Apr 2013

Study shows TOLLIP gene variant is linked to increased mortality risk in IPF patients

A new study looking at the genomes of more than 1,500 patients with idiopathic pulmonary fibrosis, a rare and devastating lung disease, found multiple genetic associations with the disease, including one gene variant that was linked to an increase in the risk of death.

17 Apr 2013

COPD phase III study by Almirall and Forest Laboratories announces positive results

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall’s inhaler Genuair® (Pressair™ in the USA).

16 Apr 2013

Frozen balls of ice can safely kill cancerous tumors in lungs

Frozen balls of ice can safely kill cancerous tumors that have spread to the lungs, according to the first prospective multicenter trial of cryoablation. The results are being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans.

15 Apr 2013

Study opens new avenues of research to improve care for patients with COPD

Researchers from Boston University School of Medicine have pinpointed a genetic signature for chronic obstructive pulmonary disease from airway cells harvested utilizing a minimally invasive procedure.

12 Apr 2013

Patients exposed to chest radiation are more likely to die after heart surgery

Patients who have open heart surgery for heart disease caused by radiation cancer treatment are nearly twice as likely to die in the years following their surgery compared to similar patients who did not undergo radiation treatment, according to new research from Cleveland Clinic published today in the American Heart Association journal Circulation.

9 Apr 2013

Finding solutions to protect U.S. troops against invisible killers

A Saint Louis University researcher has received a contract worth up to $980,000 to see if two cancer medications have the potential of protecting U.S. troops from biological agents that could be unleashed during an attack.

4 Apr 2013

V/Q imaging can detect early stages of COPD

In vivo ventilation/perfusion (V/Q) imaging can detect early changes to the lung caused by cigarette smoke exposure and provides a noninvasive method for studying lung dysfunction in preclinical models, according to research published in the April issue of The Journal of Nuclear Medicine.

2 Apr 2013

HAP caused by exposure to biomass fuels increases mortality risk

Almost four million people die each year from household air pollution (HAP) caused by exposure to the combustion of biomass fuels (wood, charcoal, crop residues, and dung), kerosene, or coal.

2 Apr 2013

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.

2 Apr 2013

Scientists identify potential treatment for idiopathic pulmonary fibrosis

Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.

25 Mar 2013

SLU researcher studies effect of bitter melon extract on treating cancer

A Saint Louis University researcher has received a $39,425 grant from the Lottie Caroline Hardy Charitable Trust to continue her research on treating cancer with a natural substance -- the extract taken from a vegetable that is part of her diet.

24 Mar 2013

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

The Coalition for Pulmonary Fibrosis, the Pulmonary Fibrosis Foundation, and the American Thoracic Society-the world's leading professional organization for pulmonary, critical care and sleep medicine-today announced that the CPF and the PFF will again partner with the ATS to fund pulmonary fibrosis research.

21 Mar 2013

Research findings could lead to new treatments for lung disorders in premature babies

Researchers at Yale School of Medicine have made major discoveries that could lead to new treatments for lung disorders in premature babies. In a mouse study, the team located key molecules that switch on stress pathways in preterm lung disorders, and also found that when parts of these pathways were blocked with a pain drug, lung damage was prevented or reversed.

21 Mar 2013

University of Pittsburgh researchers receive NIH grant to develop wearable artificial lung

Each year, nearly 350,000 Americans die of some form of lung disease, with another 150,000 patients needing short- and long-term care. Unfortunately, current breathing-support technologies are cumbersome, often requiring patients to be bedridden and sedated.

20 Mar 2013

Scientist awarded $1.2M grant to develop therapy to reduce premature births

A scientist at Case Western Reserve University School of Medicine has been awarded a $1.2 million grant to develop a therapy to reduce the prevalence of premature births, which today affect more than 15 million newborns worldwide each year.

11 Mar 2013

Fatigue linked to COPD severity, hospitalization risk

Fatigue is associated with disease severity in patients with chronic obstructive pulmonary disease, researchers confirm.

8 Mar 2013

Lung Disease News and Research

IP-10 and neopterin show promise as biomarkers for lung disease exacerbations

SLU study reveals that access to dermatologists limited for Medicaid-insured children with eczema

Longer looks: Paying the oncologist; plenty of diagnostic errors, a patient revolution

Study identifies seven new genetic regions associated with pulmonary fibrosis

Study shows TOLLIP gene variant is linked to increased mortality risk in IPF patients

COPD phase III study by Almirall and Forest Laboratories announces positive results

Frozen balls of ice can safely kill cancerous tumors in lungs

Study opens new avenues of research to improve care for patients with COPD

Patients exposed to chest radiation are more likely to die after heart surgery

Finding solutions to protect U.S. troops against invisible killers

V/Q imaging can detect early stages of COPD

HAP caused by exposure to biomass fuels increases mortality risk

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

Scientists identify potential treatment for idiopathic pulmonary fibrosis

SLU researcher studies effect of bitter melon extract on treating cancer

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

Research findings could lead to new treatments for lung disorders in premature babies

University of Pittsburgh researchers receive NIH grant to develop wearable artificial lung

Scientist awarded $1.2M grant to develop therapy to reduce premature births

Fatigue linked to COPD severity, hospitalization risk

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News